Chemistry: molecular biology and microbiology – Apparatus – Mutation or genetic engineering apparatus
Reexamination Certificate
1999-11-02
2002-03-26
Beisner, William H. (Department: 1799)
Chemistry: molecular biology and microbiology
Apparatus
Mutation or genetic engineering apparatus
C600S104000, C604S070000, C128S200140, C606S119000
Reexamination Certificate
active
06361991
ABSTRACT:
FIELD OF THE INVENTION
The present patent application involves the introduction of DNA sequences encoding RNA and proteins into the differentiated tissues of a living organism. It involves a procedure by which DNA sequences can be targeted to differentiated an undifferentiated tissue and for enhancing the expression of DNA sequences in specific target cells.
BACKGROUND OF THE INVENTION
It is known in this field that a full length cottontail rabbit papillomavirus (CRPV) DNA genome of the Washington B strain of the virus can be injected into rabbit skin as an episome by several methods (See, Brandsma et al, Proc. Natl. Acad. Sci., U.S.A., Vol. 88, pages 4816-4820 (June 1991)). In the Brandsma publication, inter alia, the authors discuss, as one of the several methods of inoculating with the episome, the use of a ped-o-jet (a standard hypodermic jet injector gun) for injecting the entire viral genome of the cottontail rabbit papillomavirus (CRPV) DNA into rabbit skin. Prior to injection of the full length genome Brandsma purifies it either by using standard cesium chloride centrifugation or by using polyethylene glycol precipitation followed by proteinase K digestion. Equivalent purification results were obtained with DNA purified by either method.
The Brandsma publication alludes to the possibility that further research might lead to other forms of DNA that might also be injected using the jet injection technique, but there is no data or descriptional basis to lead one to expect any likelihood of success with injecting DNA if less than a complete genome episome.
The four different methods discussed in Brandsma et al for inoculating rabbit skin involved (a) epithelial scarification with a razor blade followed by smearing on of DNA, (b) scratching the skin with the back of an 18-gauge needle followed by smearing on of DNA, (c) intradermal inoculation and puncture 200 times with a 27-gauge needle, and (d) interdermal inoculation using a PED-O-Jet injector (Stirn Industries, Dayton, N.J.).
The four types of inoculations were performed on four to five pound random-bred New Zealand white female rabbits, anesthetized with ketamine hydrochloride (44 milligrams per kilogram) after clipping their backs free of hair. The inoculant contained 70 micrograms of supercoiled CRPV-p LAI1 DNA (wild type or mutant) per site in 0.1 milliliter of 0.15 M NaCl or 10 mM Tris.HCl/1 mM EDTA.
Inoculation methods (a) and (b) were not very efficient, but the intradermal inoculation and puncture (manual) and the jet injector methods both induced papillomas. The intradermal manual method induced papillomas in 15-25% of the inoculated sites on all the rabbits. The jet-injector caused 23-81% of the inoculated sites to form papillomas.
The Brandsma paper concluded that there was some advantage as to the total number of papillomas produced and a savings of time for the inoculation. However, it was not clear whether the increased rate of producing papillomas from the DNA episomes could also be accounted for possibly of different depths at which the injection was done into the tissue using the manual or the jet method. Further, there is no data for the manual method using a larger diameter (smaller gauge) needle for the injection. The 27 gauge needle used has a very small diameter and could possibly have broken the episome DNA into fragments.
In other words, Brandsma is not clear as to whether the jet injector and the manual injection were done at the same depth in the tissue. Possibly, one of the two methods injected deeper into the tissue or injected over a wider area of tissue. Specifically a different manual injection technique (such as injecting while withdrawing the needle instead of at just one depth) may have been much more successful than the technique used by Brandsma. Thus, the data produced in Brandsma is inconclusive on this point.
Moreover, in Brandsma there is no experimental evidence or data that would provide any reasonable basis for believing that DNA fragments which are not capable of producing an episome would be expressed if they were injected either manually or using the jet injection.
Accordingly, there is a need in this art for an improved method for initiating gene expression for DNA which corresponds to less than a complete genome, i.e., gene fragments, in a host and for improved equipment with which to perform these injections.
SUMMARY OF THE INVENTION
It is an object of the present invention to provide a method of targeting transient gene expression and stable gene expression from the exogenous administration of a DNA sequence, which sequence is less than a complete genome, wherein said DNA sequence encodes RNA and protein, or RNA only, to differentiate tissue of living organisms wherein said DNA sequence through a jet injector technique, and said DNA sequence of less than a complete genome is expressed in a living organism.
Another object of the present invention is to provide a flexible multi-nozzle injector device with a wide surface area to allow molding of the injector nozzle to the surface contours of the tissue.
Still another object of the present invention is to provide an injection device having a long nozzle for injection of DNA deep into the host tissue.
It is a further object of the present invention to provide an injector device modified to be used with and/or injected through an endoscopic device.
REFERENCES:
patent: 3805783 (1974-04-01), Ismach
patent: 3908651 (1975-09-01), Fudge
patent: 4333922 (1982-06-01), Herschler
patent: 4458630 (1984-07-01), Sharma et al.
patent: 4689402 (1987-08-01), Sekine et al.
patent: 5041244 (1991-08-01), Baron
patent: 5080648 (1992-01-01), D'Antonio
patent: 5141131 (1992-08-01), Miller, Jr et al.
patent: 5336228 (1994-08-01), Cholhan
patent: 5507724 (1996-04-01), Hofmann et al.
patent: 0 405 696 (1991-01-01), None
patent: 0 414 044 (1991-02-01), None
patent: WO 91/00915 (1991-01-01), None
P.A. Furth et al.,Analytical Biochemistry,205 (1992): 365-368.
C. Sautter et al.,Bio/Technology,9 (1991): 1080-1085.
Buhler et al.,Biotechnology,vol. 8 (1990) pp. 140-143.
Romanczuk et al.,J. Virology,vol. 64 (#6) (1990) pp. 2849-2859.
Wolff et al.,Science,vol. 247 (1990) pp. 1465-1468.
Craigie et al.,Cell,vol. 62 (1990) pp. 829-837.
Watson et al.,N.A.R.,vol. 12 (#13) (1984) pp. 5145-5164.
Stillman et al.,Bioassays,vol. 9 (#2 &3) (1988) pp. 56-60.
C. Pittius et al.,Proc.Natl.Acad.Sci., USA,vol. 85 (1988) pp. 5874-5878.
Benvenisty et al.,Proc.Natl.Acad.Sci., USA,vol. 83 (1986) pp. 9551-9555.
D. Brown,Washington Post(Dec. 8, 1995) pp. A1 & A22.
A. Coghlan et al.,New Scientist(Nov. 25, 1995) pp. 14-15.
S. Orkin et al., NIH Gene Therapy Report (Dec. 7, 1995).
J. Ulwer et al.,Science,259:1745-9 (1993).
M. Boshant et al.,Cell,41:521-30 (1985).
C. Gorman et al.,Mol.Cell.Biol.,2(9): 1044-51 (1982).
F. Ausubel et al.,Curr.Periods in Mol. Biol.,vol. 1, John Wiley & Sons (1994-1996) p.9.0.6.
T. Friedman,Sci.Amer.Jun.(1997) pp. 96-101.
I. Verma et al.,Nature389:239-42 (1997).
C. Nicolau et al.,Proc.Natl.Acad.Sci., USA,vol. 80 (Feb. 1983) pp. 1068-1072.
C. Seeger et al.,Proc.Natl.Acad.Sci., USA,vol. 81 (Sep. 1983) pp. 5849-5852.
T.W. Dubensky et al.,Proc.Natl.Acad.Sci., USA,vol. 81 (Dec. 1985) pp. 7529-7533.
G.Y. Wu et al.,J.Biol.Chem.,vol. 263, No. 29 (Oct. 15, 1988) pp. 14621-14624.
Y. Kaneda et al.,Science,vol. 243 (Jan. 20, 1989) pp. 375-378.
T. Friedman,Science,vol. 244 (Jun. 16, 1989) pp. 1275-1281.
N. Yang,Proc.Natl.Acad.Sci., USA,vol. 87 (Dec. 1990) pp. 9568-9572.
H. Niwa et al.,Gene,vol. 108 (1991) pp. 192-200.
J. Brandsma et al.,Proc.Natl.Acad.Sci., USA,vol. 88 (Jun. 1991) pp. 4816-4820.
T. Klein et al.,Bio/Technology,vol. 10 (Mar. 1992) pp. 286-291.
D. Tang et al.,Nature,vol. 356 (Mar. 12, 1992) pp. 152-154.
Furth Priscilla Anne
Hennighausen Lothar
Beisner William H.
Fish & Richardson P.C.
The United States of America as represented by the Department of
LandOfFree
Targeting gene expression to living tissue using jet injection does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Targeting gene expression to living tissue using jet injection, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Targeting gene expression to living tissue using jet injection will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2862609